US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group NV

1.51

0.0000

Volume:- -

Turnover:- -

Market Cap:1.02B

PE:-75.29

High:1.51

Open:1.51

Low:1.51

Close:1.51

52wk High:2.17

52wk Low:0.8932

Shares:678.35M

Float Shares:656.66M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0201

EPS(LYR):-0.0161

ROE:1.02%

ROA:4.48%

PB:3.70

PE(LYR):-94.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Pharming Group NV

Exchange:

PINK LIMITED

Establishment Date:

1988

Employees:

404

Office Location:

Darwinweg 24,Leiden,Zuid-Holland,Netherlands

Website:

http://www.pharming.com

Zip Code:

2333 CR

Phone:

Fax:

31 71 524 7445

Introduction:

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHGUF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHGUF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHGUF\",,,,,undefined,":{"symbol":"PHGUF","market":"US","secType":"STK","nameCN":"Pharming Group NV","latestPrice":1.51,"timestamp":1774032480000,"preClose":1.51,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":656657486,"shares":678354310,"eps":-0.020055,"marketStatus":"Trading","change":0,"latestTime":"03-20 14:48:00 EDT Delay","open":1.51,"high":1.51,"low":1.51,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.020055,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774036800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":1.51,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHGUF\",,,,,undefined,":{"symbol":"PHGUF","floatShares":656657486,"roa":"4.48%","roe":"1.02%","lyrEps":-0.016054,"shares":678354310,"dividePrice":0,"high":1.51,"amplitude":0,"preClose":1.51,"low":1.51,"week52Low":0.8932,"pbRate":"3.70","psRate":"2.72","week52High":2.17,"institutionHeld":0,"latestPrice":1.51,"eps":-0.020055,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.020055,"open":1.51,"prevYearClose":1.65,"prevWeekClose":1.51,"prevMonthClose":1.6,"prevQuarterClose":1.65,"fiveDayClose":1.51,"twentyDayClose":1.6,"sixtyDayClose":1.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHGUF\",params:#limit:5,,,undefined,":[{"date":"2024-05-08","symbol":"PHGUF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715155200000,"name":null,"time":"Pre-Market","dateTimestamp":1715140800000,"actualEps":null},{"market":"US","date":"2022-10-27","symbol":"PHGUF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1666843200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-05-12","symbol":"PHGUF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1652328000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-03-24","symbol":"PHGUF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1648094400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHGUF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHGUF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1659672000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":32943,"yearFounded":1988,"employeeNum":404,"address":"Darwinweg 24,Leiden,Zuid-Holland,Netherlands","zipCode":"2333 CR","officePhone":"31 71 524 7400","officeFax":"31 71 524 7445"},"stockCompanyDetail":{"websiteUrl":"http://www.pharming.com","stockEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":0.1066},{"period":"3month","weight":0.5882},{"period":"6month","weight":0.4211},{"period":"1year","weight":0.3366},{"period":"ytd","weight":0.5}],"description":"Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.","exchange":"PINK LIMITED","name":"Pharming Group NV","nameEN":"Pharming Group NV"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PHGUF\",market:\"US\",,,undefined,":null}}